CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
Recruiting
N/A
Interventional Study
Cardiac Amyloidosis
Chest Pain
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 65 and older
- Sex
- Male
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 300 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this observational, prospective study is to determine the prevalence of Cardiac Amyloidosis (CA) in males over the age of 65 who experience chest pain but show no signs of coronary artery disease (CAD).
Prior to inclusion, all patients will have undergone a CT coronary angiogram or an Rb-PET scan to rule out the possibility of CAD.
Participants will be subject to several examina…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
No signs of CAD through Rb-PET and/or CT coronary arteriogram
Exclusion Criteria:
Previous history of amyloidosis
Contacts